Jason Itkin, an attorney with the Houston-based firm Arnold & Itkin, won a $70 million award in Philadelphia for a boy who claimed drugmaker Janssen Pharmaceuticals failed to warn that Risperdal, the antipsychotic drug the boy took to control his violent behavior, would lead him to grow breasts.
The verdict in A.Y. v. Janssen Pharmaceuticals was nearly 20 times larger than the amounts juries awarded to plaintiffs in the four previous Risperdal cases that went to trial combined.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
